{"recordsFiltered":49216,"recordsTotal":49216,"next":null,"previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=title&start=48900","results":[{"registry_id":"NCT02598349","publication_url":"https://clinicaltrials.gov/study/NCT02598349","title":"A Phase II Trial of Escalated Dose Proton Radiotherapy With Elective Nodal Irradiation and Concomitant Chemotherapy for Patients With Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2016-04-30","completion_date":"2039-10-31","has_results":false,"results_due":false,"sponsor_name":"Proton Collaborative Group","sponsor_slug":"proton-collaborative-group","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT06617286","publication_url":"https://clinicaltrials.gov/study/NCT06617286","title":"MAC-CAR: A Phase 1B/II Trial of Myeloablative Conditioning and Autologous Stem Cell Transplantation Followed by Autologous CD30+ CAR T Cells in Children, Adolescents and Young Adults With Poor-Risk Classical Hodgkin Lymphoma (cHL)","has_exemption":false,"start_date":"2026-12-01","completion_date":"2039-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03007589","publication_url":"https://clinicaltrials.gov/study/NCT03007589","title":"Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics","has_exemption":false,"start_date":"2014-04-30","completion_date":"2040-01-31","has_results":false,"results_due":false,"sponsor_name":"Sun Protection Foundation","sponsor_slug":"sun-protection-foundation","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05568719","publication_url":"https://clinicaltrials.gov/study/NCT05568719","title":"A PHASE 3, NON-INVESTIGATIONAL PRODUCT, MULTI COUNTRY COHORT STUDY TO DESCRIBE THE LONG-TERM SAFETY AND EFFECTIVENESS OF A PRIOR SINGLE-DOSE TREATMENT WITH INVESTIGATIVE GIROCTOCOGENE FITELPARVOVEC OR FIDANACOGENE ELAPARVOVEC IN PARTICIPANTS WITH HEMOPHILIA A OR HEMOPHILIA B, RESPECTIVELY","has_exemption":false,"start_date":"2022-12-28","completion_date":"2040-02-25","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05849480","publication_url":"https://clinicaltrials.gov/study/NCT05849480","title":"A Phase I/II Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)","has_exemption":false,"start_date":"2024-05-08","completion_date":"2040-06-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05620771","publication_url":"https://clinicaltrials.gov/study/NCT05620771","title":"Phase II Study Therasphere® (Yttrium-90) in Combination With Systemic Therapy in Patients With High-risk Hepatocellular Carcinoma","has_exemption":false,"start_date":"2022-11-30","completion_date":"2040-07-01","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02689440","publication_url":"https://clinicaltrials.gov/study/NCT02689440","title":"Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib and Venetoclax: A Phase II Study","has_exemption":false,"start_date":"2016-02-19","completion_date":"2040-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT07073014","publication_url":"https://clinicaltrials.gov/study/NCT07073014","title":"A Phase 3, Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy of Vosoritide in Children With Hypochondroplasia","has_exemption":false,"start_date":"2025-06-20","completion_date":"2040-12-31","has_results":false,"results_due":false,"sponsor_name":"BioMarin Pharmaceutical","sponsor_slug":"biomarin-pharmaceutical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02760849","publication_url":"https://clinicaltrials.gov/study/NCT02760849","title":"WISP (Women Choosing Surgical Prevention)","has_exemption":false,"start_date":"2016-05-02","completion_date":"2041-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT07095452","publication_url":"https://clinicaltrials.gov/study/NCT07095452","title":"Phase 2/3, Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Subjects With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant","has_exemption":false,"start_date":"2026-01-08","completion_date":"2042-01-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05962346","publication_url":"https://clinicaltrials.gov/study/NCT05962346","title":"Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion for Severe Left Congenital Diaphragmatic Hernia","has_exemption":false,"start_date":"2026-12-31","completion_date":"2043-07-31","has_results":false,"results_due":false,"sponsor_name":"Mauro H. Schenone","sponsor_slug":"mauro-h-schenone","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03486873","publication_url":"https://clinicaltrials.gov/study/NCT03486873","title":"A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants Who Are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab","has_exemption":false,"start_date":"2018-08-21","completion_date":"2043-08-04","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06281730","publication_url":"https://clinicaltrials.gov/study/NCT06281730","title":"Use of New Generation Fetoscopes in Pregnancies Affected by Fetal Diseases Amenable to Fetoscopy Therapy","has_exemption":false,"start_date":"2024-03-23","completion_date":"2044-02-29","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06358638","publication_url":"https://clinicaltrials.gov/study/NCT06358638","title":"Sickle Cell Disease Transplant Using a Nonmyeloablative Approach: Adding Daratumumab for Patients With Anti-donor Red Cell AntibodY","has_exemption":false,"start_date":"2024-04-03","completion_date":"2044-09-30","has_results":false,"results_due":false,"sponsor_name":"Children's National Research Institute","sponsor_slug":"childrens-national-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01538056","publication_url":"https://clinicaltrials.gov/study/NCT01538056","title":"Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysm: An Investigator Initiated Study","has_exemption":false,"start_date":"2011-03-31","completion_date":"2045-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02917460","publication_url":"https://clinicaltrials.gov/study/NCT02917460","title":"Genomic Biorepository: Protocol for the Collection, Storage, Analysis, and Distribution of Biological Samples, Genomic and Clinical Data","has_exemption":false,"start_date":"2016-07-31","completion_date":"2050-12-31","has_results":false,"results_due":false,"sponsor_name":"Rady Pediatric Genomics & Systems Medicine Institute","sponsor_slug":"rady-pediatric-genomics-systems-medicine-institute","status":"ongoing","is_pact":true,"days_late":null}]}